Results 41 to 50 of about 51,568 (202)

Neutrophilic Dermatoses in a Clinical Practice of Wound Care Professionals

Advances in Skin & Wound Care, 2022
Diagnosing and treating neutrophilic dermatoses (NDs) in clinical practice can be challenging because of various presentations and stubborn treatment responses.
T. Lapa, R. Sibbald, P. Coutts, Xiu Zhao
semanticscholar   +1 more source

Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa

JEADV Clinical Practice, EarlyView.
ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori, Manabu Fujimoto, Katsuto Tamai   +2 more
wiley   +1 more source

Neutrophilic dermatoses in a patient with collagenous colitis

Dermatology Reports, 2010
We report the case of a 75-year old woman with collagenous colitis who presented with erythematous and edematous plaques on the periorbital and eyelid regions, accompanied by oral ulcers.
Didac Barco, Maria A. Barnadas, Esther Roé, Francisco J. Sancho, Elena Ricart, Agustín Alomar   +5 more
doaj   +2 more sources

Neutrophilic pustular eruption with behcet's like illness post Covid-19 vaccination

Indian Dermatology Online Journal, 2022
The COVID-19 pandemic has deeply impacted the lives of many. In such unprecedent times, mass vaccination has been the cornerstone in decreasing morbidity and mortality.
Anmol Bhargava, Vidya Kharkar, Sunanda Mahajan, Prachi Gole   +3 more
doaj   +1 more source

Pyoderma Gangrenosum of the Breast: A Rare Location of Neutrophilic Dermatoses

Scholars Journal of Medical Case Reports, 2022
Pyoderma gangrenosum (PG) is a rare entity belonging to the neutrophilic dermatoses. It is an inflammatory dermatosis with a chronic evolution by relapses, often revealing an associated underlying disease. The location to the breast represents is unusual,
S. Abdel-Ilah, N. Chadia, M. Aboudouraib, S. Amal, O. Hocar   +4 more
semanticscholar   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation

Medical Sciences, 2021
This short note presents previous research data supporting a pilot study of metronomic dapsone during the entire course of glioblastoma treatment. The reviewed data indicate that neutrophils are an integral part of human glioblastoma pathophysiology ...
Richard E. Kast
doaj   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source

Mucocutaneous adverse events to immune checkpoint inhibitors

Frontiers in Allergy, 2023
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy. Since the approval of ipilimumab in 2011, a total of nine ICIs have gained indications for various solid and hematologic malignancies.
Fiorinda Muhaj, Padmavathi V. Karri, Padmavathi V. Karri, Wylie Moody, Alexandria Brown, Anisha B. Patel   +5 more
doaj   +1 more source

Neutrophilic dermatoses as a manifestation of a systemic lupus erythematosus flare

Lupus
Neutrophilic dermatoses (NDs) refer to a group of cutaneous conditions histologically characterized by the dense accumulation of neutrophils in the skin in the absence of infection.
Yingxue Wang, Eugenia Chen, Priyanka Iyer   +2 more
semanticscholar   +1 more source